Navigation Links
Metabolic Solutions Development Company announces publication of data describing a new drug target for diabetes
Date:5/15/2013

ex in the regulation of metabolic function to develop several classes of novel insulin sensitizers, which do not have the side effects that have prevented the development of new therapeutic treatments for type 2 diabetes.

Phase 2 Clinical Results Support New Target Hypothesis
Phase 2b clinical data published in the January 18, 2013 issue of Clinical Pharmacology & Therapeutics on the company's prototype compound, MSDC-0160, a novel once-a-day oral insulin sensitizer and the first in a new class of therapeutic agents called mTOT Modulators, showed this new generation of insulin sensitizer met the study's primary endpoint of significantly reducing fasting plasma glucose (FPG) and significantly reduced hemoglobin A1c (HbA1c). The study was a 90-day, randomized, double-blind, comparator- and placebo-controlled, multi-dose study completed in 258 patients with type 2 diabetes. The study compared three doses of MSDC-0160 (50 mg, 100 mg and 150 mg) to maximum dose Actos (pioglitazone 45 mg) or placebo taken orally once daily for 12 weeks. All treatments were well tolerated. There were no serious adverse events attributed by investigators to the MSDC drug.

About Metabolic Solutions Development Company
Metabolic Solutions Development Company (www.msdrx.com) is a drug discovery and development company investigating novel molecular targets and developing new therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially type 2 diabetes.

1 Bricker, et al. (2012) A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337, 96-100; and Herzig, et al. (2012) Identification and functional expression of the mitochondrial pyruvate carrier. Science 337, 93-96.

2 Colca,
'/>"/>

SOURCE Metabolic Solutions Development Company, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Metabolic Pathways Collection at SRI International the Largest in the World
2. Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical Implications of Newly FDA-Approved Treatment for Homozygous Familial Hypercholesterolemia
3. Highly efficient production of advanced biofuel by metabolically engineered microorganism
4. Metabolic engineer synthesizes key breast milk ingredient, makes research possible
5. Profil Institute Continues to Publish New Findings in Metabolic Research
6. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
7. GenoVive, a pioneer in DNA-based weight management solutions, today announced the companys first European partnership as of May 1, 2013 with DNADIETA based in Poland.
8. Integrated Service Solutions, Inc. Celebrates 15 Years in Business
9. BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013
10. Elissa Guerra Joins Pursuit as VP of Client Solutions
11. Challenges and Solutions in Conducting Biosimilar Trials, New Life Science Webinar Hosted by Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Incorporated (SPEX) -- an intellectual property development company committed to ... the United States Patent & Trademark Office (USPTO) issued a ... that is part of a standard essential family of patents. ... , Application number: US 13/728,867 , Publication date: Sep ... The listed inventors of the new patent, entitled ...
(Date:9/20/2014)... Massachusetts, USA (PRWEB) September 20, 2014 ... prestigious 2015 Prism Awards for Photonics Innovation . ... from the multi-billion dollar optics and photonics industry, and ... optics and photonics , and Photonics Media . ... as the versatility of photonics, said SPIE CEO Eugene ...
(Date:9/19/2014)... is rarely simple. From crop yields to disease risks, ... those considered "complex traits." Just as for heightthe textbook ... particular human disease are shaped by multiple genetic and ... involved. To track down such genes, geneticists typically mate ... large mouse and a small mouseand then study their ...
(Date:9/19/2014)... Sept. 19, 2014  An entire month is dedicated ... neuropathies – Charcot-Marie-Tooth disease (CMT) – a debilitating neuromuscular ... extreme muscle atrophy, weakness, and foot and hand deformities. ... millions worldwide. CMT is a progressive disease, and over ... requiring mobility devices such as leg braces, wheelchairs and ...
Breaking Biology Technology:Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 2Spherix Notified by United States Patent & Trademark Office of New Standard Essential Patent Issued to Spherix 3Entry deadline is 10 October for international photonics Prism Awards 2Entry deadline is 10 October for international photonics Prism Awards 3Entry deadline is 10 October for international photonics Prism Awards 4Want to link genes to complex traits? Start with more diversity 2September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2
... , , INDIANAPOLIS, Sept. 2 ... announced that, effective October 1, 2009, it would increase the ... kg for all non-contract customers or as existing contracts permit. ... invest in expanding global supply for the high performance, reducing ...
... WILMINGTON, Delaware, September 2 According ... (2009 - 2014), published,by MarketsandMarkets ( http://www.marketsandmarkets.com ), ... US$19.4 billion by 2014, recording,a CAGR of 89.1% ... patients,insurers, and government agencies to reduce the costs ...
... , SOUTH PLAINFIELD, N.J., Sept. 2 ... and licensing agreement with Roche for the development of orally bioavailable ... (GEMS(TM)). The collaboration focuses initially on four CNS disease targets ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO ) , , ...
Cached Biology Technology:MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014 2MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014 3PTC Therapeutics Announces Drug Discovery Collaboration With Roche 2PTC Therapeutics Announces Drug Discovery Collaboration With Roche 3
(Date:9/21/2014)... researchers has developed a protein therapy that disrupts the ... original tumor sites, travel through the blood stream and ... This process, known as metastasis, can cause cancer to ... patients who succumb to cancer fall prey to metastatic ... professor of bioengineering who describes a new therapeutic approach ...
(Date:9/19/2014)... fairness did not evolve for the sake of fairness ... of continued cooperation, so say Frans de Waal, PhD, ... about inequity aversion (IA), which is defined as a ... in Science . , Their conclusion comes ... to address their hypothesis that it is the evolution ...
(Date:9/18/2014)... new GSA Bulletin study uses tree rings ... and Chaco Wash in northern New Mexico, USA. By ... and willow, investigators were able to precisely date arroyo ... combined this data with aerial imagery, LiDAR, longitudinal profiles, ... arroyos. , Arroyos are deep, oversized channels that have ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7
... build tannins, complex chemicals used by plants for defence ... discovered organelle that is found in most land plants. ... they are single-celled organisms like amoeba, or enormous entities ... up the body of the organism). Although cells may ...
... University of Alberta have made a basic science discovery ... When DNA becomes too damaged it ultimately leads to ... Glover and his colleagues published their findings in the ... summer. For years, scientists thought two key proteins involved ...
... landmark study that has discovered four novel gene variations ... meta-analysis, involving nearly 30,000 African-Americans, also found that the ... pressure across other populations. Epidemiology and biostatistics ... paper, which appears in The American Journal of ...
Cached Biology News:New cell component important to tea and wine-making 2Discovery about DNA repair could lead to improved cancer treatments 2African-American study identifies 4 genetic variants associated with blood pressure 2
FluoSpheres® biotin-labeled microspheres, 0.2 µm, yellow-green fluorescent (505/515) *1% solids*...
GM130 Immunogen: Recombinant purified rat GM130 Family / Subclass 1: Signal Transduction Storage: 4 C...
... Anti-NY-ESO-1, clone E978 ... : NM_001327 Immunogen ... protein Formulation: mouse ascites ... Quality Assurance: routinely evaluated ...
R26.4C...
Biology Products: